BAROnova® Secures $27.3M Investment To Fund Clinical Trial For Weight-loss Device

GOLETA, Calif., Feb. 15, 2013 — BAROnova, Inc., announced today the closing of its Series C financing of $27.3 million, led by investments from Sante Ventures and Boston Scientific Corporation, a leading innovator of medical devices and technologies.